About
Cyril De Colle is Principal at CDC Pharma Consulting, LLC, with over 25 years of experience in discovery research and clinical development in the biopharmaceutical industry. He is the founder and Chief Scientific Officer of Neurograstrx, and has worked on small molecule drug products for gastroenterology, neurology, and psychiatry indications, spanning target identification, drug discovery, regulatory submissions, and clinical studies. His background includes business development, licensing and acquisitions, and fundraising exceeding $125M, along with more than 20 peer-reviewed publications and patents.
Founder at Neurogastrx
Intro paths
→
In turn, Cyril can intro founders to Neurogastrx's investors below.
Neurogastrx's investors · 7
5AM VenturesBoston · $100K – $4M checksOrbiMedNew York · $1M – $75M checks · since 2021Samsara BioCapitalPalo AltovenBio Global StrategicSan Francisco · since 2021venBio PartnersSan FranciscoVivo CapitalPalo Alto · $10M – $50M checksWestlake Village BioPartnersLos Angeles · $100K – $5M checks · since 2021
Executive at Neurogastrx
Intro paths
→
In turn, Cyril can intro founders to Neurogastrx's investors below.
Neurogastrx's investors · 7
5AM VenturesBoston · $100K – $4M checksOrbiMedNew York · $1M – $75M checks · since 2021Samsara BioCapitalPalo AltovenBio Global StrategicSan Francisco · since 2021venBio PartnersSan FranciscoVivo CapitalPalo Alto · $10M – $50M checksWestlake Village BioPartnersLos Angeles · $100K – $5M checks · since 2021
Co-founders at Neurogastrx
CD
Cyril De ColleFounder
Experience
- CDC Pharma Consulting, LLCPrincipalcurrent2026 — presentNorth America
- Neurogastrx, Inc.Founder & Chief Scientific Officer2011 — 2025California, United States
- C.DC Pharma ConsultingPharmaceutical Professional2010 — 2017San Francisco Bay Area
- KineMed, IncVice President, Neuroscience2009 — 2010Emeryville, CA
- Jazz PharmaceuticalsSenior Clinical Scientist2007 — 2008
- AmgenSenior Scientist2005 — 2007
- RocheResearch Scientist2001 — 2005
- Parke DavisResearch Scientist1998 — 2000
- MapiClinical Research Associate1997 — 1998
Skills & more
ConsultingScientific BackgroundDue DiligenceAudio ConferencingToxicologyPre-clinical StudiesPatent LawDrug Discovery70Pharmacology35Clinical Development29Neuroscience32Drug Development32
+11 more
BiotechnologyAssay DevelopmentLife SciencesClinical TrialsClinical ResearchCellIn VitroBiochemistryCommunicationPharmaceutical IndustryCROLanguages English · French · Spanish
From Cyril's professional profile.
Frequently asked questions
- Who is Cyril De Colle?
- Cyril De Colle is Principal at CDC Pharma Consulting, LLC, with over 25 years of experience in discovery research and clinical development in the biopharmaceutical industry. He is the founder and Chief Scientific Officer of Neurograstrx, and has worked on small molecule drug products for gastroenterology, neurology, and psychiatry indications, spanning target identification, drug discovery, regulatory submissions, and clinical studies. His background includes business development, licensing and acquisitions, and fundraising exceeding $125M, along with more than 20 peer-reviewed publications and patents.
- Where does Cyril De Colle work?
- Cyril De Colle is Founder of Neurogastrx.
- What companies did Cyril De Colle found?
- Cyril De Colle founded Neurogastrx.
- Where did Cyril De Colle go to school?
- Cyril De Colle studied at Université Montpellier II (Ph.D., Science); Université Montpellier II (MS, Molecular and Cellular Pharmacology).
Shared employers
Also worked at Neurogastrx, Inc.2
Also worked at Jazz Pharmaceuticals7
Elena VibochManaging Director at General CatalystDenise KnoppingVP of People at Longitude CapitalSamir MalhotraInvestment Partner at Civilization Ventures Management, LlcLawrence CarterFellow at High Street Equity PartnersKevin CraigChief Medical Officer at atai Life SciencesVanhoveVenture Partner at Longitude Capital
+ 1 more
Also worked at Amgen86
Parker ConradCo-founder & CEO of RipplingSeth LieblichInvestment Team at 8VCSean BruichChief Technology Officer at Flare Capital PartnersSteph ScottVice President at Questa CapitalBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersKelli McKeirnanDirector of Administration at Westlake Village BioPartners
+ 80 more
